Building a search engine for exposures in disease

Building a search engine to ﬁnd
environmental and phenotypic factors
associated with disease and health
Chirag J Patel

University of Puerto Rico, Humacao U-STAR

02/21/17
chirag@hms.harvard.edu
@chiragjp
www.chiragjpgroup.org

P = G + EType 2 Diabetes

Cancer

Alzheimer’s

Gene expression
Phenotype Genome
Variants
Environment
Infectious agents

Nutrients

Pollutants

Drugs

We are great at G investigation!
over 2400

Genome-wide Association Studies (GWAS)

https://www.ebi.ac.uk/gwas/
G

Nothing comparable to elucidate E inﬂuence!
E: ???
We lack high-throughput methods
and data to discover new E in P…

A similar paradigm for discovery should exist

for E!
Why?

P = G + EType 2 Diabetes

Cancer

Alzheimer’s

Gene expression
Phenotype Genome
Variants
Environment
Infectious agents

Nutrients

Pollutants

Drugs
Remember….

σ2
P = σ2
G + σ2
E
+ (σ2
ExG + σ2
GxG)

σ2
G
σ2P
H2 =
Heritability (H2) is the range of phenotypic
variability attributed to genetic variability in a
population
Indicator of the proportion of phenotypic
diﬀerences attributed to G.

Height is an example of a heritable trait:

Francis Galton shows how its done (1887)
“mid-height of 205 parents
described 60% of variability of 928
offspring”

Height is an example of a heritable trait:

Francis Galton shows how its done (1887)
“mid-height of 205 parents
described 60% of variability of 928
offspring”
what explains the other 40%???

nutrition?

economics?

Eye color
Hair curliness
Type-1 diabetes
Height
Schizophrenia
Epilepsy
Graves' disease
Celiac disease
Polycystic ovary syndrome
Attention deficit hyperactivity disorder
Bipolar disorder
Obesity
Alzheimer's disease
Anorexia nervosa
Psoriasis
Bone mineral density
Menarche, age at
Nicotine dependence
Sexual orientation
Alcoholism
Lupus
Rheumatoid arthritis
Crohn's disease
Migraine
Thyroid cancer
Autism
Blood pressure, diastolic
Body mass index
Depression
Coronary artery disease
Insomnia
Menopause, age at
Heart disease
Prostate cancer
QT interval
Breast cancer
Ovarian cancer
Hangover
Stroke
Asthma
Blood pressure, systolic
Hypertension
Osteoarthritis
Parkinson's disease
Longevity
Type-2 diabetes
Gallstone disease
Testicular cancer
Cervical cancer
Sciatica
Bladder cancer
Colon cancer
Lung cancer
Leukemia
Stomach cancer
0 25 50 75 100
Heritability: Var(G)/Var(Phenotype) Source: SNPedia.com
G estimates for burdensome diseases are low and variable:
massive opportunity for high-throughput E discovery
Type 2 Diabetes
Heart Disease
Autism (50%???)

Eye color
Hair curliness
Type-1 diabetes
Height
Schizophrenia
Epilepsy
Graves' disease
Celiac disease
Polycystic ovary syndrome
Attention deficit hyperactivity disorder
Bipolar disorder
Obesity
Alzheimer's disease
Anorexia nervosa
Psoriasis
Bone mineral density
Menarche, age at
Nicotine dependence
Sexual orientation
Alcoholism
Lupus
Rheumatoid arthritis
Crohn's disease
Migraine
Thyroid cancer
Autism
Blood pressure, diastolic
Body mass index
Depression
Coronary artery disease
Insomnia
Menopause, age at
Heart disease
Prostate cancer
QT interval
Breast cancer
Ovarian cancer
Hangover
Stroke
Asthma
Blood pressure, systolic
Hypertension
Osteoarthritis
Parkinson's disease
Longevity
Type-2 diabetes
Gallstone disease
Testicular cancer
Cervical cancer
Sciatica
Bladder cancer
Colon cancer
Lung cancer
Leukemia
Stomach cancer
0 25 50 75 100
Heritability: Var(G)/Var(Phenotype) Source: SNPedia.com
G estimates for complex traits are low and variable:
massive opportunity for high-throughput E discovery
σ2
E : Exposome!

©2015NatureAmerica,Inc.Allrightsreserved.
Despite a century of research on complex traits in humans, the
relative importance and specific nature of the influences of
genes and environment on human traits remain controversial.
We report a meta-analysis of twin correlations and reported
variance components for 17,804 traits from 2,748 publications
including 14,558,903 partly dependent twin pairs, virtually
all published twin studies of complex traits. Estimates of
heritability cluster strongly within functional domains,
and across all traits the reported heritability is 49%. For a
majority (69%) of traits, the observed twin correlations are
consistent with a simple and parsimonious model where twin
resemblance is solely due to additive genetic variation. The
data are inconsistent with substantial influences from shared
environment or non-additive genetic variation. This study
provides the most comprehensive analysis of the causes of
individual differences in human traits thus far and will guide
future gene-mapping efforts. All the results can be visualized
using the MaTCH webtool.
Specifically, the partitioning of observed variability into underlying
genetic and environmental sources and the relative importance of
additive and non-additive genetic variation are continually debated1–5.
Recent results from large-scale genome-wide association studies
(GWAS) show that many genetic variants contribute to the variation
in complex traits and that effect sizes are typically small6,7. However,
the sum of the variance explained by the detected variants is much
smaller than the reported heritability of the trait4,6–10. This ‘missing
heritability’ has led some investigators to conclude that non-additive
variation must be important4,11. Although the presence of gene-gene
interaction has been demonstrated empirically5,12–17, little is known
about its relative contribution to observed variation18.
In this study, our aim is twofold. First, we analyze empirical esti-
mates of the relative contributions of genes and environment for
virtually all human traits investigated in the past 50 years. Second, we
assess empirical evidence for the presence and relative importance of
non-additive genetic influences on all human traits studied. We rely
on classical twin studies, as the twin design has been used widely
to disentangle the relative contributions of genes and environment,
across a variety of human traits. The classical twin design is based
on contrasting the trait resemblance of monozygotic and dizygotic
twin pairs. Monozygotic twins are genetically identical, and dizygotic
twins are genetically full siblings. We show that, for a majority of traits
(69%), the observed statistics are consistent with a simple and parsi-
monious model where the observed variation is solely due to additive
genetic variation. The data are inconsistent with a substantial influence
from shared environment or non-additive genetic variation. We also
show that estimates of heritability cluster strongly within functional
domains, and across all traits the reported heritability is 49%. Our
results are based on a meta-analysis of twin correlations and reported
variance components for 17,804 traits from 2,748 publications includ-
ing 14,558,903 partly dependent twin pairs, virtually all twin studies of
complex traits published between 1958 and 2012. This study provides
the most comprehensive analysis of the causes of individual differences
in human traits thus far and will guide future gene-mapping efforts. All
Meta-analysis of the heritability of human traits based on
fifty years of twin studies
Tinca J C Polderman1,10, Beben Benyamin2,10, Christiaan A de Leeuw1,3, Patrick F Sullivan4–6,
Arjen van Bochoven7, Peter M Visscher2,8,11 & Danielle Posthuma1,9,11
1Department of Complex Trait Genetics, VU University, Center for Neurogenomics
and Cognitive Research, Amsterdam, the Netherlands. 2Queensland Brain
Institute, University of Queensland, Brisbane, Queensland, Australia. 3Institute
for Computing and Information Sciences, Radboud University Nijmegen,
Nijmegen, the Netherlands. 4Center for Psychiatric Genomics, Department
of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA.
5Department of Psychiatry, University of North Carolina, Chapel Hill, North
Carolina, USA. 6Department of Medical Epidemiology and Biostatistics,
Karolinska Institutet, Stockholm, Sweden. 7Faculty of Sciences, VU University,
Insight into the nature of observed variation in human traits is impor-
tant in medicine, psychology, social sciences and evolutionary biology.
It has gained new relevance with both the ability to map genes for
human traits and the availability of large, collaborative data sets to do
so on an extensive and comprehensive scale. Individual differences in
human traits have been studied for more than a century, yet the causes
of variation in human traits remain uncertain and controversial.
Nature Genetics, 2015
17,804 traits of the phenome
2,748 publications

14,558,903 twin pairs
Average H2 (genome): 0.49
Exposome may play an equal role.

It took a new paradigm of GWAS for discovery:
Human Genome Project to GWAS
Sequencing of the genome
2001
HapMap project:
http://hapmap.ncbi.nlm.nih.gov/
Characterize common variation
2001-current day
High-throughput variant
assay
< $99 for ~1M variants
Measurement tools
~2003 (ongoing)
ARTICLES
Genome-wide association study of 14,000
cases of seven common diseases and
3,000 shared controls
The Wellcome Trust Case Control Consortium*
There is increasing evidence that genome-wide association (GWA) studies represent a powerful approach to the
identification of genes involved in common human diseases. We describe a joint GWA study (using the Affymetrix GeneChip
500K Mapping Array Set) undertaken in the British population, which has examined ,2,000 individuals for each of 7 major
diseases and a shared set of ,3,000 controls. Case-control comparisons identified 24 independent association signals at
P , 5 3 1027
: 1 in bipolar disorder, 1 in coronary artery disease, 9 in Crohn’s disease, 3 in rheumatoid arthritis, 7 in type 1
diabetes and 3 in type 2 diabetes. On the basis of prior findings and replication studies thus-far completed, almost all of these
signals reflect genuine susceptibility effects. We observed association at many previously identified loci, and found
compelling evidence that some loci confer risk for more than one of the diseases studied. Across all diseases, we identified a
25 27
Vol 447|7 June 2007|doi:10.1038/nature05911
WTCCC, Nature, 2008.
Comprehensive, high-throughput analyses
GWAS

Explaining the other 50%:
A big data-driven paradigm for robust discovery of
E in disease via EWAS and the exposome
what to measure? how to measure?
PERSPECTIVES
Xenobiotics
Inflammation
Preexisting disease
Lipid peroxidation
Oxidative stress
Gut flora
Internal
chemical
environment
Externalenvironment
ExposomeRADIATION
DIET
POLLUTION
INFECTIONS
DRUGS
LIFE-STYLE
STRESS
Reactive electrophiles
Metals
Endocrine disrupters
Immune modulators
Receptor-binding proteins
itical entity for disease eti-
ogy (7). Recent discussion
as focused on whether and
ow to implement this vision
8). Although fully charac-
rizing human exposomes
daunting, strategies can be
eveloped for getting “snap-
hots” of critical portions of
person’s exposome during
ifferent stages of life. At
ne extreme is a “bottom-up”
rategy in which all chemi-
als in each external source
f a subject’s exposome are
easured at each time point.
lthoughthisapproachwould
ave the advantage of relat-
g important exposures to
e air, water, or diet, it would
quire enormous effort and
ould miss essential compo-
ents of the internal chemi-
al environment due to such
actors as gender, obesity,
ﬂammation, and stress. By
ontrast, a “top-down” strat-
gy would measure all chem-
als (or products of their
ownstream processing or
ffects, so-called read-outs
r signatures) in a subject’s
ood. This would require
nly a single blood specimen
each time point and would relate directly ruptors and can be measured through serum
some (telomere) length in
peripheral blood mono-
nuclear cells responded
to chronic psychological
stress, possibly mediated
by the production of reac-
tive oxygen species (15).
Characterizing the
exposome represents a tech-
nological challenge like that of
thehumangenomeproject,which
began when DNA sequencing
was in its infancy (16). Analyti-
cal systems are needed to pro-
cess small amounts of blood from
thousands of subjects. Assays
should be multiplexed for mea-
suring many chemicals in each
class of interest. Tandem mass
spectrometry, gene and protein
chips, and microﬂuidic systems
offer the means to do this. Plat-
forms for high-throughput assays
shouldleadtoeconomiesofscale,
again like those experienced by
the human genome project. And
because exposome technologies
would provide feedback for thera-
peuticinterventionsandpersonal-
ized medicine, they should moti-
vate the development of commer-
cial devices for screening impor-
tant environmental exposures in
blood samples.
With successful characterization of both
Characterizing the exposome. The exposome represents
the combined exposures from all sources that reach the
internal chemical environment. Toxicologically important
classes of exposome chemicals are shown. Signatures and
biomarkers can detect these agents in blood or serum.
onOctober21,2010www.sciencemag.orgrom
“A more comprehensive view of
environmental exposure is
needed ... to discover major
causes of diseases...”
how to analyze in relation to health?
Wild, 2005

Rappaport and Smith, 2010, 2011

Buck-Louis and Sundaram 2012

Miller and Jones, 2014

Patel CJ and Ioannidis JPAI, 2014

What is a Genome-Wide Association Study (GWAS)?:
Data-driven search for G factors in P
evolut
partic
eases;
tase 1)
well a
biolog
The
captur
implem
STRU
revert
subset
librium
clearly
−log10(P)
0
5
10
15
Chromosome
22
X
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
80
60
40
100
rvedteststatistic
a
b
NATURE|Vol 447|7 June 2007
WTCCC, 2007
AA Aa aa
case
control
Robust, transparent, and comprehensive search for G in P

evolu
parti
eases
tase 1
well
biolo
Th
captu
imple
STRU
rever
subse
libriu
clearl
−log10(P)
0
5
10
15
Chromosome
22
X
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
80
60
40
100
ervedteststatistic
a
b
NATURE|Vol 447|7 June 2007
comprehensive
and transparent
multiplicity
controlled
novel
ﬁndings
(and validated)
Patel CJ, Ioannidis JPAI, JAMA 2014
Patel CJ, Ioannidis JPAI, JECH 2014
Why carry out a Genome-Wide Association Study:
Analytically robust, transparent, and comprehensive

search for G in P

GWAS example
Example of the big data paradigm:

GWAS to drives discovery in G in P
A RT I C L E S
50 Locus established previously
Locus identified by current study
Locus not confirmed by current study
BCL11A
THADA
NOTCH2
ADAMTS9
IRS1
IGF2BP2
WFS1
ZBED3
CDKAL1
HHEX/IDE
KCNQ1 (2 signals*: )
TCF7L2
KCNJ11
CENTD2
MTNR1B
HMGA2 ZFAND6
PRC1
FTO
HNF1B DUSP9
Conditional analysis
Unconditional analysis
TSPAN8/LGR5
HNF1A
CDC123/CAMK1D
CHCHD9
CDKN2A/2B
SLC30A8
TP53INP1
JAZF1
KLF14
PPAR
40
30
–log10(P)–log10(P)
20
10
10
1 2 3 4 5 6 7 8
Chromosome
9 10 11 12 13 14 15 16 17 18 19 20 21 22 X
0
0
Suggestive statistical association (P < 1 10
–5
)
Association in identified or established region (P < 1 10
–4
)
Figure 1 Genome-wide Manhattan plots for the DIAGRAM+ stage 1 meta-analysis. Top panel summarizes the results of the unconditional meta-
analysis. Previously established loci are denoted in red and loci identified by the current study are denoted in green. The ten signals in blue are those
taken forward but not confirmed in stage 2 analyses. The genes used to name signals have been chosen on the basis of proximity to the index SNP and
should not be presumed to indicate causality. The lower panel summarizes the results of equivalent meta-analysis after conditioning on 30 previously
established and newly identified autosomal T2D-associated SNPs (denoted by the dotted lines below these loci in the upper panel). Newly discovered
conditional signals (outside established loci) are denoted with an orange dot if they show suggestive levels of significance (P < 10−5), whereas
secondary signals close to already confirmed T2D loci are shown in purple (P < 10−4).
Voight et al, Nature Genetics 2012

N=8K T2D, 39K Controls

Impossible to reach this scale in E based investigations

Connecting E with Disease:
Missing the “System” of Exposures?
E+ E-
diseased
non-
diseased
?
Exposed to many things, but do not assess the multiplicity.
Fragmented literature of associations.
Challenge to discover E associated with disease.

Examples of exposome-driven discovery machinery

Gold standard for breadth of human exposure information:
National Health and Nutrition Examination Survey1
since the 1960s
now biannual: 1999 onwards
10,000 participants per survey
The sample for the survey is selected to represent
the U.S. population of all ages. To produce reli-
able statistics, NHANES over-samples persons 60
and older, African Americans, and Hispanics.
Since the United States has experienced dramatic
growth in the number of older people during this
century, the aging population has major impli-
cations for health care needs, public policy, and
research priorities. NCHS is working with public
health agencies to increase the knowledge of the
health status of older Americans. NHANES has a
primary role in this endeavor.
All participants visit the physician. Dietary inter-
views and body measurements are included for
everyone. All but the very young have a blood
sample taken and will have a dental screening.
Depending upon the age of the participant, the
rest of the examination includes tests and proce-
dures to assess the various aspects of health listed
above. In general, the older the individual, the
more extensive the examination.
Survey Operations
Health interviews are conducted in respondents’
homes. Health measurements are performed in
specially-designed and equipped mobile centers,
which travel to locations throughout the country.
The study team consists of a physician, medical
and health technicians, as well as dietary and health
interviewers. Many of the study staff are
bilingual (English/Spanish).
An advanced computer system using high-
end servers, desktop PCs, and wide-area
networking collect and process all of the
NHANES data, nearly eliminating the need
for paper forms and manual coding operations.
This system allows interviewers to use note-
book computers with electronic pens. The staff
at the mobile center can automatically transmit
data into data bases through such devices as
digital scales and stadiometers. Touch-sensi-
tive computer screens let respondents enter
their own responses to certain sensitive ques-
tions in complete privacy. Survey information
is available to NCHS staff within 24 hours of
collection, which enhances the capability of
collecting quality data and increases the speed
with which results are released to the public.
In each location, local health and government
officials are notified of the upcoming survey.
Households in the study area receive a letter
from the NCHS Director to introduce the
survey. Local media may feature stories about
the survey.
NHANES is designed to facilitate and en-
courage participation. Transportation is provided
to and from the mobile center if necessary.
Participants receive compensation and a report
of medical findings is given to each participant.
All information collected in the survey is kept
strictly confidential. Privacy is protected by
public laws.
Uses of the Data
Information from NHANES is made available
through an extensive series of publications and
articles in scientific and technical journals. For
data users and researchers throughout the world,
survey data are available on the internet and on
easy-to-use CD-ROMs.
Research organizations, universities, health
care providers, and educators benefit from
survey information. Primary data users are
federal agencies that collaborated in the de-
sign and development of the survey. The
National Institutes of Health, the Food and
Drug Administration, and CDC are among the
agencies that rely upon NHANES to provide
data essential for the implementation and
evaluation of program activities. The U.S.
Department of Agriculture and NCHS coop-
erate in planning and reporting dietary and
nutrition information from the survey.
NHANES’ partnership with the U.S. Environ-
mental Protection Agency allows continued
study of the many important environmental
influences on our health.
• Physical fitness and physical functioning
• Reproductive history and sexual behavior
• Respiratory disease (asthma, chronic bron-
chitis, emphysema)
• Sexually transmitted diseases
• Vision
1 http://www.cdc.gov/nchs/nhanes.htm
>250 exposures (serum + urine)
GWAS chip
>85 quantitative clinical traits
(e.g., serum glucose, lipids, body
mass index)
Death index linkage (cause of
death)

Gold standard for breadth of exposure & behavior data:
National Health and Nutrition Examination Survey
Nutrients and Vitamins

vitamin D, carotenes
Infectious Agents

hepatitis, HIV, Staph. aureus
Plastics and consumables

phthalates, bisphenol A
Physical Activity

e.g., stepsPesticides and pollutants

atrazine; cadmium; hydrocarbons
Drugs

statins; aspirin

What exposures are correlated with type 2 diabetes?

Type 2 Diabetes Mellitus:
A complex, multifactorial disease
•Insulin production vs. use

•beta-cell function

•insulin sensitivity (BMI)

•Moves glucose from blood into
cells

•Complications arise due to
glucose in blood, hyperglycemia
•diagnosed by blood glucose
levels

CDC,
body weight, diet, lifestyle, age

EWAS in Type 2 Diabetes:
>200 associations with a Manhattan Plot−log10(pvalue)
●
●
●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
● ●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●● ●
●●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●
●
●●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●
●
● ●
acrylamide
allergentest
bacterialinfection
cotinine
diakyl
dioxins
furansdibenzofuran
heavymetals
hydrocarbons
latex
nutrientscarotenoid
nutrientsminerals
nutrientsvitaminA
nutrientsvitaminB
nutrientsvitaminC
nutrientsvitaminD
nutrientsvitaminE
pcbs
perchlorate
pesticidesatrazine
pesticideschlorophenol
pesticidesorganochlorine
pesticidesorganophosphate
pesticidespyrethyroid
phenols
phthalates
phytoestrogens
polybrominatedethers
polyflourochemicals
viralinfection
volatilecompounds
012
Heptachlor Epoxide
OR=3.2, 1.8
PCB170
OR=4.5,2.3
γ-tocopherol (vitamin E)
OR=1.8,1.6
β-carotene
OR=0.6,0.6
FBG > 125 mg/dL

adjusted by age, sex, race, SES, BMI
PLOS ONE. 2010
FDR<10%

What E are correlated with heart disease risk factors?

EWAS on Serum Lipid Levels:
Triglycerides, LDL-Cholesterol, HDL-Cholesterol
• Risk factors for coronary heart disease (CHD)

• Targets for intervention (ie, statins)

• Inﬂuenced by smoking, physical activity, diet,
genetics1
Teslovich et al. Nature (2010)

Grundy et al. ATVB (2004)

Gotto et al. JACC (2004)
• LDL-C Δ1%: 1% increased risk for
CHD2

• HDL-C Δ1%: 2% decreased risk for
CHD3

• Triglycerides: higher risk for CHD image: google.com

EWAS in HDL-C:
17 Validated Factors
FDR < 5%
carotenes
cotinine
heavy metals
organochlorine pesticides
Int J Epidem. 2012
hydrocarbons
log10(HDL-C)

adjusted for BMI, SES, ethnicity, age, age2, sex

N=1000-3000
E
Vitamins
DCBA
minerals
1-5 mg/dL

R2 ~ 15%

EWAS in Triglycerides and LDL-C
22 factors
organochlorine pesticides

polychlorinated biphenyls

carotenoids

vitamin E

vitamin A
8 factors
carotenoids

vitamin E

vitamin A
Int J Epidem. 2012.
1-15 mg/dL

R2 ~ 15, 2%

Eﬀect Sizes For Validated Factors:
HDL-C
% change = Δ 1 SD in Exposure

17 validated factors
survey! N! P-value! FDR! Effect (mg/dL)!
pollutants nutrient factors
R2 ~ 15%
Int J Epidem. 2012.

Persistent pollutants and endocrine disruptors found in
T2D and Heart Disease risk factors:
How are these factors linked with these diseases?
•organochlorine pesticides

•polychlorinated biphenyls

•dibenzofurans

•dioxins
•found all over the world

•persist in food chain

Porta et al, Environ Int 2008
•heart disease,

•T2D/insulin resistance

Porta et al, Lancet, 2006

Lee et al, Diabetes Care, 2006

Lee et al, Diabetologia, 2007

Everett et al, Environ Res, 2010

Lind et al, EHP, 2011

(Korea, Japan, Europe)
Biological mechanisms remain elusive...
capacitors

adhesives

Challenges in exposome data mining:
confounding and reverse causality hinder inference!
example: HDL-C
Could the disease “lead” to
exposure?

“Reverse causality”
γ-tocopherol
?
tocopherol (vitamin e) supplements for

T2D individuals?
T2D
Could there something confounding
the association?
statin use
β-carotene
confounders
high HDL
??

Longitudinal Study:
“Silver Standard” to mitigate risk of reverse
•exposure changing through time

•reverse causality bias

•compute disease risk
age/time
HDL-Cholesterol
(mg/dL)
[high]
[low]
[γ-tocopherol]
tocopherol (vitamin e) supplements for

CHD individuals?
T2D
?
γ-tocopherol

age/time
Rateofmortality
[high]
[low]
[E factors]
What environmental factors associated with long-term risk for death?

What E are associated with aging:

all-cause mortality and telomere length?

How does it work?:
Searching for exposures and behaviors associated with all-
cause mortality.
NHANES: 1999-2004
National Death Index linked mortality
246 behaviors and exposures (serum/urine/self-report)
NHANES: 1999-2001
N=330 to 6008 (26 to 655 deaths)
~5.5 years of followup
Cox proportional hazards
baseline exposure and time to death
False discovery rate < 5%
NHANES: 2003-2004
N=177 to 3258 (20-202 deaths)
~2.8 years of followup
p < 0.05
Int J Epidem. 2013

Adjusted Hazard Ratio
-log10(pvalue)
0.4 0.6 0.8 1.0 1.2 1.4 1.6 2.0 2.4 2.8
02468
1
2
3
4
5
67
1 Physical Activity
2 Does anyone smoke in home?
3 Cadmium
4 Cadmium, urine
5 Past smoker
6 Current smoker
7 trans-lycopene
(11) 1
2
3 4
5 6
78
9
10 1112
13 14
1516
1 age (10 year increment)
2 SES_1
3 male
4 SES_0
5 black
6 SES_2
7 SES_3
8 education_hs
9 other_eth
10 mexican
11 occupation_blue_semi
12 education_less_hs
13 occupation_never
14 occupation_blue_high
15 occupation_white_semi
16 other_hispanic
(69)
EWAS in All-cause mortality:
253 exposure/behavior associations in survival
Multivariate Cox (age, sex, income, education, race/ethnicity, occupation [in
red])
FDR < 5%
sociodemographics
replicated factor
Int J Epidem. 2013

Adjusted Hazard Ratio
-log10(pvalue)
0.4 0.6 0.8 1.0 1.2 1.4 1.6 2.0 2.4 2.8
02468
1
2
3
4
5
67
1 Physical Activity
2 Does anyone smoke in home?
3 Cadmium
4 Cadmium, urine
5 Past smoker
6 Current smoker
7 trans-lycopene
(11) 1
2
3 4
5 6
78
9
10 1112
13 14
1516
1 age (10 year increment)
2 SES_1
3 male
4 SES_0
5 black
6 SES_2
7 SES_3
8 education_hs
9 other_eth
10 mexican
11 occupation_blue_semi
12 education_less_hs
13 occupation_never
14 occupation_blue_high
15 occupation_white_semi
16 other_hispanic
(69)
EWAS (re)-identiﬁes factors associated with all-cause mortality:

Volcano plot of 200 associations
age (10 years)
income (quintile 2)
income (quintile 1)
male
black income (quintile 3)
any one smoke in home?
Multivariate cox (age, sex, income, education, race/ethnicity, occupation [in red])
serum and urine cadmium
[1 SD]
past smoker?
current smoker?serum lycopene
[1SD]
physical activity
[low, moderate, high activity]*
*derived from METs per activity and categorized by Health.gov guidelines
R2 ~ 2%

What exposures modulate telomere
length?

452 associations in Telomere Length:
Polychlorinated biphenyls associated with longer telomeres?!
0
1
2
3
4
−0.2 −0.1 0.0 0.1 0.2
effect size
−log10(pvalue)
PCBs
FDR<5%
Trunk Fat
Alk. PhosCRP
Cadmium
Cadmium (urine)cigs per day
retinyl stearate
R2 ~ 1%
VO2 Maxpulse rate
shorter telomeres longer telomeres
adjusted by age, age2, race, poverty, education, occupation
median N=3000; N range: 300-7000 IJE, 2016

Samples exposed to PCBs associated with difference in genes

implicated in telomere length GWAS?
Expression differences for 24 GWAS implicated genes
Queried the Gene Expression Omnibus for PCBs

Affymetrix human arrays (GPL570)

7 gene expression experiments on humans

52 exposed; 14 unexposed
Differential gene expression and a functional analysis of PCB-exposed children:
Understanding disease and disorder development
Sisir K. Dutta a,
⁎, Partha S. Mitra a,1
, Somiranjan Ghosh a,1
, Shizhu Zang a,1
, Dean Sonneborn b
,
Irva Hertz-Picciotto b
, Tomas Trnovec c
, Lubica Palkovicova c
, Eva Sovcikova c
,
Svetlana Ghimbovschi d
, Eric P. Hoffman d
a
Molecular Genetics Laboratory, Howard University, Washington, DC, USA
b
Department of Public Health Sciences, University of California Davis, Davis, CA, USA
c
Slovak Medical University, Bratislava, Slovak Republic
d
Center for Genetic Medicine, Children's National Medical Center, Washington, DC, USA
a b s t r a c ta r t i c l e i n f o
Article history:
Received 20 December 2010
Accepted 10 July 2011
The goal of the present study is to understand the probable molecular mechanism of toxicities and the
associated pathways related to observed pathophysiology in high PCB-exposed populations. We have
performed a microarray-based differential gene expression analysis of children (mean age 46.1 months) of
Environment International 40 (2012) 143–154
Contents lists available at ScienceDirect
Environment International
journal homepage: www.elsevier.com/locate/envint
IJE, 2016

Suggestive, but need more N!
0
1
2
−0.50 −0.25 0.00 0.25 0.50 0.75
log(difference)
−log10(pvalue)
1555203_s_at (SLC44A4)
1555203_s_at (MYNN)
224206_x_at (MYNN)
Could PCBs inﬂuence expression of genes

implicated in telomere length GWAS?
myoneurin

bladder, leukemia, colorectal cancer GWASs
IJE, 2016

Studying the Elusive Environment in Large Scale
Itispossiblethatmorethan50%ofcomplexdiseaserisk
isattributedtodifferencesinanindividual’senvironment.1
Airpollution,smoking,anddietaredocumentedenviron-
mental factors affecting health, yet these factors are but
a fraction of the “exposome,” the totality of the exposure
loadoccurringthroughoutaperson’slifetime.1
Investigat-
ing one or a handful of exposures at a time has led to a
highly fragmented literature of epidemiologic associa-
tions. Much of that literature is not reproducible, and se-
lectivereportingmaybeamajorreasonforthelackofre-
producibility. A new model is required to discover
environmental exposures associated with disease while
mitigating possibilities of selective reporting.
Toremedythelackofreproducibilityandconcernsof
validity, multiple personal exposures can be assessed si-
multaneously in terms of their association with a condi-
tion or disease of interest; the strongest associations can
then be tentatively validated in independent data sets
(eg, as done in references 2 and 3).2,3
The main advan-
tages of this process include the ability to search the list
ofexposuresandadjustformultiplicitysystematicallyand
reportalltheprobedassociationsinsteadofonlythemost
significant results. The term “environment-wide associa-
tion studies” (EWAS) has been used to describe this ap-
proach (an analogy to genome-wide association stud-
ies).Forexample,Wangetal4
screenedmorethan2000
chemicalsinserumtodiscoverendogenousexposuresas-
sociated with risk for cardiovascular disease.
Therearenotablehurdlesinanalyzing“big”environ-
mental data. These same problems affect epidemiology
of1-risk-factor-at-a-time,butinEWAStheirprevalencebe-
comes more clearly manifest at large scale. When study-
the EWAS vantage point, intervening on β-carotene
(Figure, D) seems a futile exercise given its complex rela-
tionship with other nutrients and pollutants.
Giventhiscomplexity,howcanstudiesofenvironmen-
talriskmoveforward?First,EWASanalysesshouldbeap-
pliedtomultipledatasets,andconsistencycanbeformally
examinedforallassessedcorrelations.Second,thetempo-
ral relationship between exposure and changes in health
parametersmayofferhelpfulhintsaboutwhichofthesig-
nalsaremorethansimplecorrelations.Third,standardized
adjustedanalyses,inwhichadjustmentsareperformedsys-
tematicallyandinthesamewayacrossmultipledatasets,
may also help. This is in stark contrast with the current
model,wherebymostepidemiologicstudiesusesingledata
setswithoutreplicationaswellasnon–time-dependentas-
sessments,andreportedadjustmentsaremarkedlydiffer-
entacrossreportsanddatasets,eventhoseperformedby
thesameteam(differentapproachesincreasevaliditybut
mustbereconciledandassimilated).
However, eventually for most environmental cor-
relates,theremaybeunsurpassabledifficultyestablish-
ing potential causal inferences based on observational
data alone. Factors that seem protective may some-
times be tested in randomized trials. The complexity of
the multiple correlations also highlights the challenge
thatinterveningtomodify1putativeriskfactoralsomay
inadvertently affect multiple other correlated factors.
Even when a seemingly simple intervention is tested in
randomizedtrials(affectingasingleriskfactoramongthe
manycorrelations),theinterventionisnotreallysimple.
In essence what is tested are multiple perturbations of
factors correlated with the one targeted for interven-
VIEWPOINT
Chirag J. Patel, PhD
Center for Biomedical
Informatics, Harvard
Medical School,
Boston, Massachusetts.
John P. A. Ioannidis,
MD, DSc
Stanford Prevention
Research Center,
Department of Health
Research and Policy,
Department of
Medicine, Stanford
University School of
Medicine, Stanford,
California, Department
of Statistics, Stanford
Humanities and
Sciences, Stanford,
California, and
Meta-Research
Innovation Center at
Stanford (METRICS),
Stanford, California.
Opinion
JAMA, 2014
JECH, 2014
Proc Symp Biocomp, 2015
How can we study the elusive environment in larger scale for
biomedical discovery?
Studying the Elusive Environment in Large Scale
Itispossiblethatmorethan50%ofcomplexdiseaserisk
isattributedtodifferencesinanindividual’senvironment.1
Airpollution,smoking,anddietaredocumentedenviron-
mental factors affecting health, yet these factors are but
a fraction of the “exposome,” the totality of the exposure
loadoccurringthroughoutaperson’slifetime.1
Investigat-
ing one or a handful of exposures at a time has led to a
highly fragmented literature of epidemiologic associa-
tions. Much of that literature is not reproducible, and se-
lectivereportingmaybeamajorreasonforthelackofre-
producibility. A new model is required to discover
environmental exposures associated with disease while
mitigating possibilities of selective reporting.
Toremedythelackofreproducibilityandconcernsof
validity, multiple personal exposures can be assessed si-
multaneously in terms of their association with a condi-
tion or disease of interest; the strongest associations can
then be tentatively validated in independent data sets
(eg, as done in references 2 and 3).2,3
The main advan-
tages of this process include the ability to search the list
ofexposuresandadjustformultiplicitysystematicallyand
reportalltheprobedassociationsinsteadofonlythemost
significant results. The term “environment-wide associa-
tion studies” (EWAS) has been used to describe this ap-
the EWAS vantage point, intervening on β-carotene
(Figure, D) seems a futile exercise given its complex rela-
tionship with other nutrients and pollutants.
Giventhiscomplexity,howcanstudiesofenvironmen-
talriskmoveforward?First,EWASanalysesshouldbeap-
pliedtomultipledatasets,andconsistencycanbeformally
examinedforallassessedcorrelations.Second,thetempo-
ral relationship between exposure and changes in health
parametersmayofferhelpfulhintsaboutwhichofthesig-
nalsaremorethansimplecorrelations.Third,standardized
adjustedanalyses,inwhichadjustmentsareperformedsys-
tematicallyandinthesamewayacrossmultipledatasets
may also help. This is in stark contrast with the current
model,wherebymostepidemiologicstudiesusesingledata
setswithoutreplicationaswellasnon–time-dependentas-
sessments,andreportedadjustmentsaremarkedlydiffer-
entacrossreportsanddatasets,eventhoseperformedby
thesameteam(differentapproachesincreasevaliditybut
mustbereconciledandassimilated).
However, eventually for most environmental cor-
relates,theremaybeunsurpassabledifficultyestablish-
ing potential causal inferences based on observationa
data alone. Factors that seem protective may some-
times be tested in randomized trials. The complexity of
VIEWPOINT
Chirag J. Patel, PhD
Center for Biomedical
Informatics, Harvard
Medical School,
Boston, Massachusetts.
John P. A. Ioannidis,
MD, DSc
Stanford Prevention
Research Center,
Department of Health
Research and Policy,
Department of
Medicine, Stanford
Medicine, Stanford,
California, Department
of Statistics, Stanford
Humanities and
Sciences, Stanford,
California, and
Meta-Research
Innovation Center at
Stanford (METRICS),
Stanford, California.
Opinion
High-throughputascertainmentofendogenousindicatorsofen-
vironmentalexposurethatmayreflecttheexposomeincreasinglyat-
tractattention,andtheirperformanceneedstobecarefullyevaluated.
These include chemical detection of indicators of exposure through
metabolomics, proteomics, and biosensors.7
Eventually, patterns of
US federally funded gene expression experiment data be d
itedinpublicrepositoriessuchastheGeneExpressionOmnibu
repositoryhasbeeninstrumentalindevelopmentoftechnolo
measurement of gene expression, data standardization, and
ofdatafordiscovery.JustaswiththeGeneExpressionOmnib
Figure. Correlation Interdependency Globes for 4 Environmental Exposures (Cotinine, Mercury, Cadmium, Trans-β-Carotene) in National Healt
Nutrition Examination Survey (NHANES) Participants, 2003-2004
A Serum cotinine B Serum total mercury C Serum cadmium D Serum trans-β-carotene
37 Total correlations 42 Total correlations 68 Total correlations 68 Total correlations
Negative correlation Positive correl
Infectious
agents
Pollutants
Nutrients
and vitamins
Demographic
attributes
Eachcorrelationinterdependencyglobeincludes317environmentalexposures
representedbythenodesaroundtheperipheryoftheglobe.Pairwisecorrelations
aredepictedbyedges(lines)betweenthenodeofinterest(arrowhead)andother
nodes.Correlationswithabsolutevaluesexceeding0.2areshown(stronge
Thesizeofeachnodeisproportionaltothenumberofedgesforanode,and
thicknessofeachedgeindicatesthemagnitudeofthecorrelation.
Opinion Viewpoint
•bioinformatics to connect exposome with phenome
•new ‘omics technologies to measure the exposome
•dense correlations

•reverse causality
•confounding
•(longitudinal) publicly available data

Interdependencies of the exposome:
Correlation globes paint a complex view of exposure
Red: positive ρ

Blue: negative ρ

thickness: |ρ|
for each pair of E:

Spearman ρ

(575 factors: 81,937 correlations)
permuted data to produce

“null ρ”

sought replication in > 1
cohort
Pac Symp Biocomput. 2015

JECH. 2015

Red: positive ρ

Blue: negative ρ

thickness: |ρ|
for each pair of E:

Spearman ρ

(575 factors: 81,937 correlations)
Correlation globes paint a complex view of exposure
permuted data to produce

“null ρ”

sought replication in > 1
cohort
Pac Symp Biocomput. 2015

JECH. 2015
Eﬀective number of
variables:

500 (10% decrease)

Telomere Length All-cause mortality
http://bit.ly/globebrowse
Telomeres vs. all-cause mortality

Testing all associations systematically:

Consideration of multiplicity of hypotheses and correlational web!
Explicit in number of hypotheses
tested
False discovery rate;

family-wise error rate;

Report database size!
Does my correlation matter?
How does my new correlation
compare to the family of correlations?
0.17 (e.g., carotene and diabetes)

is average ρ much less than 0.17? greater?
ρ
JAMA 2014
JECH 2015

http://chiragjpgroup.org/exposome-analytics-course
Nam Pho

You can use these data!
http://chiragjpgroup.org/exposome-analytics-course
Contact me for project ideas!
@chiragjp

chirag_patel@hms.harvard.edu

Connecting Environmental Exposure with Disease:
Missing the “System” of Exposures?
E+ E-
diseased
non-
diseased
?
Exposed to many things, but do not assess the multiplicity.
Fragmented literature of associations.
Challenge to discover E associated with disease.

Example of fragmentation:
Is everything we eat associated with cancer?
Schoenfeld and Ioannidis, AJCN 2012
50 random ingredients from
Boston Cooking School
Cookbook
Any associated with cancer?
FIGURE 1. Effect estimates reported in the literature by malignancy type (top) or ingredient (bottom). Only ingredients with $10 studie
outliers are not shown (effect estimates .10).
Of 50, 40 studied in cancer risk
Weak statistical evidence:

non-replicated

inconsistent eﬀects

non-standardized

https://www.youtube.com/watch?v=0Rnq1NpHdmw

New ways of measuring P are here now!

Can we use them to assess E (and G)?

physical activity monitors

(ﬁtbit)
smart devices

(iOS)
personal E sensors

(exposome band?!)
propeller health

Now possible to consent thousands of people at the push
of a button! http://researchkit.org

Monitoring fasting glucose is imperative for diabetics!

Possible to survey P (fasting glucose) of diabetics
consented through ResearchKit?
Adam Brown
Stanley Shaw (MGH)

Dennis Ausiello (MGH)
http://bit.ly/glucosuccess

Does the high physical activity population have lower fasting
glucose?: YES!

mashing up 24K step counts with glucose (N=600)

Is step count on previous day associated with fasting
glucose the next day?: YES!

mashing up 24K step counts with glucose (N=600)

Age (years): 43.6

Male %: 80%

Female %: 20%
Race (%):
White: 57%
Black: 7%
Hispanic: 11%
Other: 25%
Education (%):
Some High School: 2%

High School: 8%

Some college: 20%

2-year college: 10%

4 year college: 26%
Post-college: 32%
Mean Years Diabetic: 7.8
GlucoSuccess reﬂects a unique population: must do more to
get more involved!
Comorbidities (CDC*)

Stroke: 2% (0.7%)

Heart Failure: 2% (1%)

High Blood Pressure: 47% (57%)

High Lipids: 36% (58%)

Kidney Disease: 4% (0.2%*)

Circulation problems: 8% (4%)

Eye problems: 9% (17%*)

*end-stage renal disease

*visual impairment
http://www.cdc.gov/diabetes
Body Mass Index: 31
Hemoglobin A1C: 7.7

GlucoSuccess-like apps can enable longitudinal and
dynamic surveillance of P
However: population-level diﬀerences and generalizability

Rolando Acosta, Jr
Shreyas Bhave
Sivateja Tangirala
Alan LeGoallec
Danielle Rasooly
RagGroup Team:

2 post-docs, 3 PhD, 2 MS, 1 HS, 2 visiting

Possible to discover new E using high-throughput data
(exposome, medical claims, devices) to discover the role of E
(and G) in P.
−log10(pvalue)
●
●
●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
● ●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●● ●
●●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●
●
●●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●
●
● ●
acrylamide
allergentest
bacterialinfection
cotinine
diakyl
dioxins
furansdibenzofuran
heavymetals
hydrocarbons
latex
nutrientscarotenoid
nutrientsminerals
nutrientsvitaminA
nutrientsvitaminB
nutrientsvitaminC
nutrientsvitaminD
nutrientsvitaminE
pcbs
perchlorate
pesticidesatrazine
pesticideschlorophenol
pesticidesorganochlorine
pesticidesorganophosphate
pesticidespyrethyroid
phenols
phthalates
phytoestrogens
polybrominatedethers
polyflourochemicals
viralinfection
volatilecompounds
012
A Serum cotinine B Serum total mercury
37 Total correlations 42 Total correlations 68 Total correlations 68 Total correlations
Infectious
agents
Pollutants
Nutrients
and vitamins
Demographic
attributes
P = G + E

Harvard DBMI
Isaac Kohane

Susanne Churchill

Stan Shaw

Nathan Palmer

Jenn Grandﬁeld

Sunny Alvear

Michal Preminger

Chirag J Patel

chirag@hms.harvard.edu

@chiragjp

www.chiragjpgroup.org
NIH Common Fund

Big Data to Knowledge
Acknowledgements
RagGroup
Chirag Lakhani
Adam Brown
Danielle Rasooly
Nam Pho
Jake Chung
Alan LeGoallec
Arjun Manrai

Sivateja Tangirala
Shreyas Bhave
Rolando Acosta
Dr. Edwin Traverso Aviles

Building a search engine for exposures in disease

More Related Content

What's hot

Viewers also liked

Similar to Building a search engine for exposures in disease

Recently uploaded

Building a search engine for exposures in disease